PMID- 25423015 OWN - NLM STAT- MEDLINE DCOM- 20151001 LR - 20181113 IS - 1557-8518 (Electronic) IS - 1540-4196 (Print) IS - 1540-4196 (Linking) VI - 13 IP - 1 DP - 2015 Feb TI - Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased beta-cell function. PG - 45-51 LID - 10.1089/met.2014.0095 [doi] AB - BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized as a disease continuum that is marked by metabolic changes that are present for several years, sometimes well before frank diagnosis of T2DM. Genetic predisposition, ethnicity, geography, alterations in BMI, and lipid profile are considered important markers for the pathogenesis of T2DM through mechanisms that remain unresolved and controversial. The aim of this study was to investigate the relationship between triglycerides (TGs) and beta-cell function, insulin resistance (IR), and insulin sensitivity (IS) in obese first-degree relatives of patients with T2DM (FDR-T2DM) among subjects from central Mexico with normal glucose tolerance (NGT). METHODS: We studied 372 FDR-T2DM subjects (ages,18-65) and determined body mass index (BMI), fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), insulin, and TGs levels. Subjects were categorized based on glycemic control [NGT, prediabetes (PT2DM), or T2DM]. NGT subjects were further categorized by BMI [normal weight (Ob-) or obese (Ob+)] and TGs levels (TG-, <150 mg/dL, or TG+, >/=150 mg/dL). beta-cell function, IR, and IS were determined by the homeostasis model assessment of beta-cell function (HOMA2-beta), homeostasis model assessment of insulin resistance (HOMA2-IR), and Quantitative Insulin Sensitivity Check Index (QUICKI) indices, respectively. RESULTS: The obese subjects with elevated TGs levels had 21%-60% increased beta-cell function when compared to all groups (P<0.05). In addition, this group had insulin levels, IS, and IR similar to PT2DM. Furthermore, only in obese subjects did TGs correlate with beta-cell function (rho=0.502, P<0.001). CONCLUSION: We characterized FDR-T2DM subjects from central Mexico with NGT and revealed a class of obese subjects with elevated TGs and beta-cell function, which may precede PT2DM. FAU - Torres-Rasgado, Enrique AU - Torres-Rasgado E AD - 1 Facultad de Medicina, Benemerita Universidad Autonoma de Puebla , Puebla, Puebla, Mexico. FAU - Porchia, Leonardo M AU - Porchia LM FAU - Ruiz-Vivanco, Guadalupe AU - Ruiz-Vivanco G FAU - Gonzalez-Mejia, M Elba AU - Gonzalez-Mejia ME FAU - Baez-Duarte, Blanca G AU - Baez-Duarte BG FAU - Pulido-Perez, Patricia AU - Pulido-Perez P FAU - Rivera, Alicia AU - Rivera A FAU - Romero, Jose R AU - Romero JR FAU - Perez-Fuentes, Ricardo AU - Perez-Fuentes R LA - eng GR - R01 HL096518/HL/NHLBI NIH HHS/United States GR - R01 HL-096518/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20141125 PL - United States TA - Metab Syndr Relat Disord JT - Metabolic syndrome and related disorders JID - 101150318 RN - 0 (Triglycerides) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Body Mass Index MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/epidemiology MH - *Family MH - *Family Health/statistics & numerical data MH - Female MH - Humans MH - Insulin-Secreting Cells/*physiology MH - Male MH - Mexico/epidemiology MH - Middle Aged MH - Obesity/*blood/epidemiology/*physiopathology MH - Prediabetic State/physiopathology MH - Triglycerides/*blood MH - Young Adult PMC - PMC4361158 EDAT- 2014/11/26 06:00 MHDA- 2015/10/02 06:00 PMCR- 2016/02/01 CRDT- 2014/11/26 06:00 PHST- 2014/11/26 06:00 [entrez] PHST- 2014/11/26 06:00 [pubmed] PHST- 2015/10/02 06:00 [medline] PHST- 2016/02/01 00:00 [pmc-release] AID - 10.1089/met.2014.0095 [pii] AID - 10.1089/met.2014.0095 [doi] PST - ppublish SO - Metab Syndr Relat Disord. 2015 Feb;13(1):45-51. doi: 10.1089/met.2014.0095. Epub 2014 Nov 25.